Showing results (91-100 of 470) with videos related to

Sort By:
Pageof 47
The Lancet. Rheumatology|January 25, 2024
Safety and efficacy of metformin in systemic lupus erythematosus: a multicentre, randomised, double-blind, placebo-controlled trialFangfang Sun, Hui Jing Wang, Zhe Liu, et al.
The Lancet. Rheumatology|April 4, 2024
Cranial involvement in giant cell arteritisPhilipp Bosch, Georgina Espigol-Frigolé, Maria C Cid, et al.
The Lancet. Rheumatology|September 21, 2024
The effects of age and frailty on the risks of end-stage renal disease, death, and severe infection in older adults with antineutrophil cytoplasmic antibody-associated vasculitis: a retrospective cohort studySebastian E Sattui, Bohang Jiang, Xiaoqing Fu, et al.
The Lancet. Rheumatology|February 29, 2024
A preoperative package of care for osteoarthritis, consisting of weight loss, orthotics, rehabilitation, and topical and oral analgesia (OPPORTUNITY): a two-centre, open-label, randomised controlled feasibility trialA Hamish R W Simpson, Nicholas D Clement, Sharon A Simpson, et al.
The Lancet. Rheumatology|February 25, 2024
Clinical consequences of infliximab immunogenicity and the effect of proactive therapeutic drug monitoring: exploratory analyses of the randomised, controlled NOR-DRUM trialsMarthe Kirkesæther Brun, Johanna E Gehin, Kristin Hammersbøen Bjørlykke, et al.
The Lancet. Rheumatology|February 21, 2024
Global, regional, and national burden of neck pain, 1990-2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
The Lancet. Rheumatology|November 8, 2023
Proton pump inhibitors in systemic sclerosis: a reappraisal to optimise treatment of gastro-oesophageal reflux diseaseMichael Hughes, Yannick Allanore, Murray Baron, et al.
The Lancet. Rheumatology|September 25, 2023
Sex differences in clinical outcomes and biological profiles in systemic sclerosis-associated interstitial lung disease: a post-hoc analysis of two randomised controlled trialsElizabeth R Volkmann, Donald P Tashkin, Richard Silver, et al.
The Lancet. Rheumatology|July 3, 2023
Post-COVID condition in patients with inflammatory rheumatic diseases: a prospective cohort study in the NetherlandsLaura Boekel, Sadaf Atiqi, Maureen Leeuw, et al.
The Lancet. Rheumatology|March 25, 2026
Certolizumab pegol, abatacept, tocilizumab or active conventional therapy in early rheumatoid arthritis: 48-week patient-reported outcomes from the NORD-STAR trialJon Lampa, Dan Nordström, Ronald van Vollenhoven, et al.
Pageof 47